Evidence for cytoskeletal changes secondary to plasma membrane functional alterations in the in vitro cell response to Clostridium perfringens epsilon-toxin

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 26, Issue 3, 2003, Pages 145-156

  Donelli, Gianfranco ^a   Fiorentini, Carla ^a   Matarrese, Paola ^a   Falzano, Loredana ^a   Cardines, Rita ^a   Mastrantonio, Paola ^a   Payne, Dean W ^b   Titball, Richard W ^b,c  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Clostridium perfringens; Cytoskeleton; Epsilon toxin; Membrane alteration; Vascular permeability

Indexed keywords

ACTIN; CLOSTRIDIUM TOXIN;

ANIMAL CELL; CELL INTERACTION; CELL MEMBRANE PERMEABILITY; CELL SHAPE; CELL STRAIN; CELL SWELLING; CELL VOLUME; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; CYTOSKELETON; FILOPODIUM; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; IN VITRO STUDY; INCUBATION TIME; INTERMEDIATE FILAMENT; MEMBRANE DAMAGE; MICROTUBULE; NONHUMAN; REACTION TIME; REVIEW; TEMPERATURE;

CLOSTRIDIUM; CLOSTRIDIUM PERFRINGENS;

EID: 0037401155     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0147-9571(02)00052-8     Document Type: Article

References (35)

1. McDonel JL. Toxins of Clostridium perfringens types A, B, C, D and E. In: Dorner F, Drews J, editors. Pharmacology of bacterial toxins. Oxford: Pergamon Press; 1986. p. 477-517.
2. Miserez R, Frey J, Buogo C, Capaul S, Tontis A, Burnens A, Nicolet J. Detection of alpha- and epsilon-toxigenic Clostridium perfringens type D in sheep and goats using a DNA amplification technique (PCR). Lett Appl Microbiol 1998;26:382-6.
3. Uzal FA, Kelly WR. Experimental Clostridium perfringens type D enterotoxemia in goats. Vet Pathol 1998;35:132-40.
4. Uzal FA, Kelly WR. Effects of the intravenous administration of Clostridium perfringens type D epsilon toxin on young goats and lambs. J Comp Pathol 1997;116:63-71.
5. Buxton D. The use of an immunoperoxidase technique to investigate by light and electron microscopy the sites of binding of Clostridium welchii type-D epsilon toxin in mice. J Med Microbiol 1978;11:289-92.
6. Nagahama M, Sakurai J. Distribution of labeled Clostridium perfringens epsilon toxin in mice. Toxicon 1991;29:211-7.
7. Hunter SEC, Clarke IN, Kelly DC, Titball RW. Cloning and nucleotide sequencing of the Clostridium perfringens epsilon-toxin gene and its expression in Escherichia coli. Infect Immun 1992;60:102-10.
8. Minami J, Katayama S, Matsushita O, Matsushita C, Okabe A. Lambda-toxin of Clostridium perfringens activates the precursor of epsilon-toxin by releasing its N- and C-terminal peptides. Microbiol Immunol 1997;41:527-35.
9. Liu JW, Porter AG, Wee BY, Thanabalu T. New gene from nine Bacillus sphaericus strains encoding highly conserved 35.8-kilodalton mosquitocidal toxins. Appl Environ Microbiol 1996;62:2174-6.
10. Thanabalu T, Porter AG. A Bacillus sphaericus gene encoding a novel type of mosquitocidal toxin of 31.8 kDa. Gene 1996;170:85-9.
11. Nagahama M, Sakurai J. High-affinity binding of Clostridium perfringens epsilon-toxin to rat brain. Infect Immun 1992;60:1237-40.
12. Payne DW, Williamson ED, Titball RW. The Clostridium perfringens epsilon-toxin. Rev Med Microbiol 1997;9:S28-S30.
13. Worthington RW, Mülders MSG. Effect of Clostridium perfringens epsilon toxin on the blood brain barrier of mice. Onderstepoort J Vet Res 1975;42:25-7.
14. Payne DW, Williamson ED, Havard H, Modi N, Brown J. Evaluation of a new cytotoxicity assay for Clostridium perfringens type D epsilon toxin. FEMS Microbiol Lett 1994;116:161-7.
15. Knight PA, Queminet J, Blanchard JH, Tilleray JH. In vitro tests for the measurement of clostridial toxins, toxoids and antisera II. Titration of Clostridium perfringens toxins and antitoxins in cell culture. Biologicals 1990;18:263-70.
16. Lindsay CD. Assessment of aspects of the toxicity of Clostridium perfringens epsilon-toxin using the MDCK cell line. Hum Exp Toxicol 1996;15:904-8.
17. Nagahama M, Ochi S, Sakurai J. Assembly of Clostridium perfringens epsilon-toxin on MDCK cell membrane. J Nat Toxins 1998;7:291-302.
18. Petit L, Gibert M, Gillet D, Laurent-Winter C, Boquet P, Popoff MR. Clostridium perfringens epsilon-toxin acts on MDCK cells by forming a large membrane complex. J Bacteriol 1997; 179:6480-7.
19. Percival DA, Shuttleworth AD, Williamson ED, Kelly DC. Anti-idiotypic protection against Clostridium perfringens type D. Infect Immun 1990;58:2487-92.
20. Boarer CD, Sojka MG, White VJ, Roeder PL. The production and evaluation of monoclonal antibodies to Clostridium perfringens type D epsilon toxin. J Biol Stand 1988;16:207-18.
21. Darziynkinkiewicz Z, Traganos F, Kapuscinski J, Staiano-Coco L, Melamed R. Accessibility of DNA in situ to various fluorochromes: relationship to chromatin changes during erythroid differentiation of Friend leukemia cells. Cytometry 1984;5:355-63.
22. Shapiro HM. Flow cytometric probes of early events in cell activation. Cytometry 1981;1: 301-12.
23. Hambrook JL, Lindsay CD, Hughes N. Morphological alterations in MDCK cells induced by exposure to Clostridium perfringens epsilon-toxin. Biochem Soc Trans 1995;23:44S.
24. Borrmann E, Gunther H, Kohler H. Effect of Clostridium perfringens epsilon toxin on MDCK cells. FEMS Immunol Med Microbiol 2001;31:85-92.
25. Petit L, Maier E, Gibert M, Popoff MR, Benz R. Clostridium perfringens epsilon toxin induces a rapid change of cell membrane permeability to ions and forms channels in artificial lipid bilayers. J Biol Chem 2001;276:15736-40.
26. Hecht G, Pothoulakis C, LaMont JT, Madara JL. Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. J Clin Invest 1998;82:1516-24.
27. Hecht G, Koutsouris A, Pothoulakis C, LaMont JT, Madara JL. Clostridium difficile toxin B disrupts the barrier function of T84 monolayers. Gastroenterology 1992;102:416-23.
28. Donelli G, Falzano L, Fabbri A, Fiorentini C, Mastrantonio P. Enteric toxins from bacteria colonizing human gut. Microb Ecol Health Dis 2000;2(Suppl.):194-208.
29. Matthews JB, Awtrey CS, Thompson R, Hung T, Tally KJ, Madara JL. Na(+)-K(+)-2Cl - cotransport and Cl - secretion evoked by heat-stable enterotoxin is microfilament dependent in T84 cells. Am J Physiol 1993;265:G370-8.
30. Boquet P. The cytotoxic necrotizing factor 1 (CNF1) from Escherichia coli. Toxicon 2001;39: 1673-80.
31. Koshy SS, Montrose MH, Sears CL. Human intestinal epithelial cells swell and demonstrate actin rearrangement in response to the metalloprotease toxin of Bacteroides fragilis. Infect Immun 1996;64:5022-8.
32. Donelli G, Fabbri A, Fiorentini C. Bacteroides fragilis enterotoxin induces cytoskeletal changes and surface blebbing in HT-29 cells. Infect Immun 1996;64:113-9.
33. Cortes-Bratti X, Chaves-Olarte E, Lagergard T, Thelestam M. The cytolethal distending toxin from the chancroid bacterium Haemophilus ducreyi induces cell-cycle arrest in the G2 phase. J Clin Invest 1999;103:107-15.
34. Just I, Wilm, M, Selzer J, Rex G, von Eichel-Streiber C, Mann M, Aktories K. The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J Biol Chem 1995;270: 13932-6.
35. Fiorentini C, Gauthier M, Donelli G, Boquet P. Bacterial toxins and Rho GTP-binding protein: what microbes teach us about cell regulation. Cell Death Diff 1998;5:720-8.